Cardlytics (CDLX) Competitors

Cardlytics (NASDAQ:CDLX) and TruBridge (NASDAQ:TBRG) are both small-cap business services companies, but which is the superior business? We will contrast the two companies based on the strength of their dividends, profitability, media sentiment, risk, valuation, institutional ownership, analyst recommendations, earnings and community ranking.

Does the media favor CDLX or TBRG?

In the previous week, TruBridge had 4 more articles in the media than Cardlytics. MarketBeat recorded 6 mentions for TruBridge and 2 mentions for Cardlytics. Cardlytics' average media sentiment score of 1.11 beat TruBridge's score of 1.00 indicating that Cardlytics is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Cardlytics	2 Very Positive mention(s)	0 Positive mention(s)	0 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive
TruBridge	3 Very Positive mention(s)	1 Positive mention(s)	0 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive

Do institutionals & insiders have more ownership in CDLX or TBRG?

68.1% of Cardlytics shares are held by institutional investors. Comparatively, 88.6% of TruBridge shares are held by institutional investors. 4.4% of Cardlytics shares are held by company insiders. Comparatively, 10.7% of TruBridge shares are held by company insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a stock is poised for long-term growth.

Do analysts rate CDLX or TBRG?

Cardlytics currently has a consensus price target of $5.20, suggesting a potential upside of 161.31%. TruBridge has a consensus price target of $21.25, suggesting a potential downside of 14.73%. Given Cardlytics' higher probable upside, research analysts plainly believe Cardlytics is more favorable than TruBridge.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Cardlytics	1 Sell rating(s)	5 Hold rating(s)	0 Buy rating(s)	1 Strong Buy rating(s)	2.14
TruBridge	0 Sell rating(s)	2 Hold rating(s)	2 Buy rating(s)	0 Strong Buy rating(s)	2.50

Is CDLX or TBRG more profitable?

TruBridge has a net margin of -17.72% compared to Cardlytics' net margin of -93.55%. TruBridge's return on equity of 1.78% beat Cardlytics' return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Cardlytics	-93.55%	-110.67%	-32.70%
TruBridge	-17.72%	1.78%	0.78%

Does the MarketBeat Community believe in CDLX or TBRG?

Cardlytics received 216 more outperform votes than TruBridge when rated by MarketBeat users. However, 69.23% of users gave TruBridge an outperform vote while only 56.68% of users gave Cardlytics an outperform vote.

Company	Underperform	Outperform
Cardlytics	Outperform Votes 225 56.68%	Underperform Votes 172 43.32%
TruBridge	Outperform Votes 9 69.23%	Underperform Votes 4 30.77%

Which has more volatility and risk, CDLX or TBRG?

Cardlytics has a beta of 1.3, suggesting that its stock price is 30% more volatile than the S&P 500. Comparatively, TruBridge has a beta of 0.65, suggesting that its stock price is 35% less volatile than the S&P 500.

Which has higher earnings & valuation, CDLX or TBRG?

TruBridge has higher revenue and earnings than Cardlytics. TruBridge is trading at a lower price-to-earnings ratio than Cardlytics, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Cardlytics	$272.59M	0.38	-$134.70M	-$3.56	-0.56
TruBridge	$345.74M	1.08	-$44.76M	-$1.35	-18.46

Summary

TruBridge beats Cardlytics on 13 of the 19 factors compared between the two stocks.